Associate Professor Meg Jardine is a clinical researcher at The George Institute for Global Health. She is currently supported by a Next Generation Clinical Researchers Career Development Fellowship, funded by the Australian Government’s Medical Research Future Fund. She is head of George Clinical Renal Trials, a conjoint associate professor of medicine at The University of New South Wales and a practising nephrologist.
Associate Professor Jardine is the current deputy chair (chair elect) of the Scientific Committee of the Australasian Kidney Trials Network (AKTN) and the immediate past chair of the Haemodialysis Working Group, AKTN. She is a member of the ISN Advancing Clinical Trials Committee, the National Nephrology Association (ANZSN) Research Advisory Committee and the Can-SOLVE CKD International Research Advisory Committee. She has contributed to working groups and conferences of the International Society of Nephrology and the international KDIGO guidelines group, and sits on the editorial board of the Clinical Journal of the American Society of Nephrology.
Associate Professor Jardine’s research interests centre on the use of innovative and cost-effective methodologies used to investigate the impact of pharmaceutical, device and health service interventions on outcomes for people with chronic disease. Her research has focussed on investigating the progression and complications of kidney disease and diabetes through epidemiological analyses of large scale datasets and the development and implementation of randomised clinical trials.